IL4 rs2243250: Allergic Trait Association & Promoter Genetics
The rs2243250 variant is a well-studied single nucleotide polymorphism located in the promoter region of the interleukin-4 (IL4) gene, frequently referred to in literature as C-590T or C-589T. Published research associates this regulatory variant with altered promoter activity, T-helper 2 (Th2) immune responses, and circulating immunoglobulin E (IgE) levels. Carrying the variant allele has been statistically linked to conditions such as allergic rhinitis, atopic asthma, and eczema, though the strength and consistency of these associations vary substantially across ancestral groups.
What each genotype means
Baseline IL-4 promoter activity
This genotype represents the common baseline sequence for the IL4 promoter region. Research suggests this version of the gene may be associated with different levels of IL-4 expression compared to the T allele, though findings regarding its specific impact on allergic conditions remain mixed and inconsistent across different populations.
This is the most common genotype in European populations, though it is significantly less frequent in East Asian populations.
Intermediate IL-4 promoter activity
Carrying one copy of the T allele may influence the promoter activity of the IL4 gene, which is involved in immune regulation. Some studies have explored links between this variant and susceptibility to allergic rhinitis or asthma, but the evidence is limited and results vary significantly depending on ancestry and environmental factors.
This heterozygous genotype is found at varying frequencies globally, appearing more frequently in populations where the T allele is common.
Enhanced IL-4 promoter activity
The T allele is associated with enhanced promoter activity of the IL4 gene, which can influence Th2-driven immune responses and IgE production. While some research links this genotype to an altered risk profile for allergic conditions or specific cardiovascular outcomes, these associations are not definitive and may not apply to all individuals.
This genotype is most common in East Asian populations, where the T allele frequency is approximately 0.70, and is less common in European populations.
Genetic Architecture and Position of rs2243250
Located on the long arm of chromosome 5 (5q31.1), rs2243250 is positioned upstream in the non-coding promoter region of the IL4 gene. Because it lies approximately 589 to 590 base pairs upstream of the transcription initiation site, historical and functional literature predominantly labels it as C-590T or C-589T. As a promoter variant, it does not alter the underlying amino acid sequence of the interleukin-4 protein itself. Instead, in vitro assays indicate that substituting cytosine (C) with thymine (T) alters the binding affinity of specific nuclear transcription factors to the DNA sequence. This change in binding properties modifies transcription efficiency, which can lead to measurable differences in baseline and stimulus-induced IL4 gene expression.
Biological Function of the IL4 Gene
The IL4 gene encodes interleukin-4, a major cytokine secreted by activated T-helper type 2 (Th2) lymphocytes, mast cells, and basophils. Interleukin-4 serves as a master regulator in humoral immunity and allergic inflammation. One of its foundational roles is guiding naive helper T cells to differentiate into Th2 effector cells while concurrently driving B cells to switch antibody classes toward immunoglobulin E (IgE). In a well-regulated immune system, IL-4 aids in defense against extracellular parasites and promotes tissue remodeling. However, excessive or prolonged IL-4 signaling heightens type 2 inflammation, driving eosinophil recruitment and the mucosal hypersensitivity typical of allergic diseases.
Clinical Research and Evidence Strength
Multiple candidate gene association studies and meta-analyses have evaluated rs2243250 in connection with allergic conditions, such as allergic rhinitis, atopic dermatitis, and asthma severity. The T allele is frequently correlated with elevated circulating total IgE and heightened susceptibility to environmental allergen sensitization. Nonetheless, the overall clinical evidence remains classified as limited and mixed. While significant associations often replicate in East Asian and selected European cohort analyses, other diverse populations show weak or non-significant effects. Discrepancies across studies stem from small sample sizes, variable environmental allergen exposures, and complex interactions with adjacent cytokine genes, such as IL13 and IL4RA.
Global Allele Frequencies and Ancestral Variation
The prevalence of the rs2243250 alternative allele displays considerable geographical stratification across continental human ancestries. In European populations, the T allele is relatively uncommon, occurring with an estimated frequency of approximately 0.15. It shows intermediate prevalence in South Asian populations at roughly 0.25. By contrast, the T allele is common in East Asian cohorts, reaching frequencies around 0.70. Due to these notable ancestral disparities, the baseline distribution of homozygous (TT) and heterozygous (CT) genotypes differs markedly worldwide, underscoring the necessity of controlling for population structure when interpreting individual genetic findings.
Practical Interpretation and Limitations
A consumer finding their rs2243250 genotype in personal genomic data should view it strictly as a single marker within a multifaceted biological network, rather than a clinical diagnosis. Carrying one or two T alleles does not guarantee the emergence of allergies, eczema, or asthma, nor does a CC genotype ensure lifelong immunity to atopic diseases. Atopy is a polygenic trait driven by hundreds of genetic variants operating alongside critical environmental triggers like air pollution, childhood microbiome diversity, and allergen contact. Genetic insights cannot replace clinical diagnostic assessments, such as skin prick tests or allergen-specific serum IgE measurements directed by an allergist.
How common is this variant?
The T allele frequency of rs2243250 is approximately 0.15 in individuals of European ancestry, around 0.25 in South Asian populations, and reaches approximately 0.70 in East Asian groups.
Frequently asked questions
What is the rs2243250 variant in the IL4 gene?
The rs2243250 variant, also referred to as C-590T or C-589T, is a single nucleotide variation located in the promoter region of the interleukin-4 (IL4) gene. It alters the regulatory region controlling how actively the IL-4 cytokine is produced by immune cells.
Does having the T allele mean I will develop allergies or asthma?
No. The T allele is merely associated with a statistical change in the risk of elevated IgE levels and allergic traits across studied populations. Allergic conditions are complex polygenic traits heavily influenced by personal environmental exposures and lifestyle.
Why is rs2243250 called C-590T in some research papers?
Earlier scientific publications frequently named promoter variants based on their exact distance in base pairs upstream from the transcription start site. Thus, C-590T and C-589T refer to the exact same physical DNA variant as rs2243250.
Can this genetic variant guide my medical allergy treatments?
No, rs2243250 is not an established clinical pharmacogenomic marker used to prescribe or adjust allergy therapies. Clinical care, allergy testing, and management strategies should be discussed directly with an allergist or physician based on your symptoms.
Sources & further reading
Educational information only, last refreshed 9/8/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2243250?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in IL4
An intronic IL4 variant associated with heightened susceptibility to beta-lactam and penicillin immediate allergic reactions.
Variant within the IL4 gene region significantly associated with risk of penicillin hypersensitivity and immediate allergic reactions.
Intron-1 polymorphism in IL4; studies on its association with IgE levels and allergy susceptibility have yielded inconsistent results across populations.
Promoter polymorphism (-589C>T) that enhances IL-4 transcription and elevates total serum IgE, conferring heightened susceptibility to atopic dermatitis and allergic asthma.
Located in the Th2 cytokine locus between IL4 and KIF3A, this variant is robustly associated with overall food allergy risk independent of atopic dermatitis status.